Taxane anticancer formulations: challenges and achievements
Author | Abdelbary M.A., Elhissi |
Author | Mahmood, Rukhsana |
Author | Parveen, Ishrat |
Author | Vali, Asma |
Author | Najlah, Mohammad |
Author | Phoenix, David A. |
Author | Ahmed, Waqar |
Available date | 2021-01-03T11:21:05Z |
Publication Date | 2020-12-31 |
Publication Name | Advances in Medical and Surgical Engineering |
Identifier | http://dx.doi.org/10.1016/B978-0-12-819712-7.00018-8 |
Citation | Elhissi, A. M., Mahmood, R., Parveen, I., Vali, A., Najlah, M., Phoenix, D. A., & Ahmed, W. (2020). Taxane anticancer formulations: challenges and achievements. In Advances in Medical and Surgical Engineering (pp. 347-358). Academic Press. |
ISBN | 9780128197127 |
Abstract | Taxanes represent a prominent anticancer family. Paclitaxel and docetaxel are the most well-known taxanes owing to their activity against many types of cancers. The poor solubility of taxanes in water is a major obstacle toward the development of taxane formulations. In this chapter, an introduction about taxanes in terms of their pharmacology, solubility, and stability was provided. Then, we reviewed the traditional delivery systems of taxanes (e.g., formulations of paclitaxel solubilized in Cremophor EL) and the novel nanocarrier systems based on using lipid and polymeric materials. Commercially available formulations of paclitaxel such as Taxol, Abraxane, and Genexol-PM were discussed in this chapter. |
Sponsor | This chapter was written using the effort hours of a grant given by QNRF. This work was made possible by using the effort hours of the NPRP grant (grant number 337-3-069) from the Qatar National Research Fund (QNRF; a member of Qatar Foundation). The review conducted in this chapter is solely the responsibility of the authors. |
Language | en |
Publisher | Academic Press |
Subject | cancer solubility taxanes anticancer formulation nanocarrier |
Type | Book chapter |
Pagination | 347-358 |
Check access options
Files in this item
This item appears in the following Collection(s)
-
Pharmacy Research [1243 items ]